TA

Tempus AI

IPO

It's About Time

Public · Chicago, United States · Founded 2015 · $760.0M raised

Headquarters
Chicago, Illinois
Employees
1001–5000
Founded
2015
Business Model
B2B
Total Funding
$760.0M
Last Round
$200.0M Series G+Oct 2021
Rounds
6
Type
Public

About

Tempus AI is a health technology company that applies artificial intelligence to genomic, clinical, and molecular data to enable precision medicine across oncology, neurology, cardiology, and radiology. Its platform includes genomic profiling, AI-powered diagnostics, real-world data products, and clinical trial matching for both healthcare providers and life sciences companies. Founded in 2015 by Eric Lefkofsky, Tempus went public on Nasdaq in 2024.

Summary

Tempus AI is an Artificial Intelligence company based in Chicago, United States, founded in 2015. It has raised $760.0M in total across 6 rounds, most recently a $200.0M Series G+ round in Oct 2021. Investors include Baillie Gifford, Franklin Templeton and Google.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

IPOJun 2024
$410.7M

Sign up to see all 7 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies